Keywords: |
controlled study; unclassified drug; cancer localization; nonhuman; disease marker; cancer diagnosis; binding affinity; sensitivity analysis; animal cell; mouse; animal tissue; animal experiment; animal model; in vivo study; drug structure; in vitro study; tumor xenograft; drug design; drug synthesis; cetuximab; drug accumulation; drug distribution; malignant neoplastic disease; adsorption; biocompatibility; dye; epidermal growth factor receptor antibody; drug stability; particle size; design; resonance; drug solubility; transmission electron microscopy; gold; absorption; thiophene derivative; limit of detection; surface property; sorption; raman spectroscopy; raman spectrometry; gold nanoparticle; female; article; nanoprobe; 4 (3 (2,6 dithiophen 2 yl 4h thiopyran 4 ylidene)prop 1 enyl) (2,6 dithiophen 2 yl)thiopyrylium hexafluorophosphate; 4 [3 (2,6 diphenyl 4h selenopyran 4 ylidene)prop 1 enyl] 2,6 diphenylselenopyrylium; 4 [3 (2,6 diphenyl 4h thiopyran 4 ylidene)prop 1 enyl] 2,6 diphenylselenopyrylium hexafluorophosphate; 4 [3 (2,6 dithiophen 2 yl 4h thiopyran 4 ylidene)prop 1 enyl] 2,6 diphenylselenophyrylium; 4 [3 (2,6 dithiophen 2 yl 4h thiopyran 4 ylidene)prop 1 enyl] 2,6 diphenylthiopyrylium hexafluorophosphate; counterion; cyanine dye; ir 792; optical method
|